INDIANAPOLIS — An Indianapolis company, Patients Choice Laboratories (PCL), announced Monday it will pay more than $9.6 million to the state of Indiana to settle a case involving false billing to Medicare for COVID-19 and other infectious disease tests. The laboratory denies any wrongdoing in the case.

The U.S. Department of Justice (DOJ) claimed that from December 2020 to May 2022, PCL knowingly submitted claims to Medicare for respiratory pathogen panels, or RPPs, that were either medically unnecessary or obtained through illegal kickbacks.

The government says PCL was hired by the government to perform infectious disease testing, like COVID-19 swabbing, in long-term care facilities. Even though PCL was paid for this service, the company is accused of using the same specimens to bill Me

See Full Page